Physician profile
Krisha Howell
NPI 1134327554
$1,057.99
in general payments reported to CMS, 2019-2025
14 companies · $518 in 2025
The $518 reported for 2025 was more than what 75% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.48 · 2021: $96.74 · 2022: $76.02 · 2023: $49.02 · 2024: $299 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $350.83 | 2024-2025 | Barrigel |
| Elekta, INC. | $297.76 | 2021-2024 | |
| Boston Scientific Corporation | $111.06 | 2025 | Spaceoar Vue System - 10ml |
| Novocure INC. | $56.28 | 2025 | Optune Gio, Optune Lua (Novottf-200t) |
| Sumitomo Pharma America, INC. | $41.36 | 2024 | Orgovyx |
| Blue Earth Diagnostics | $33.26 | 2023 | |
| Novartis Pharmaceuticals Corporation | $32.50 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.57 | 2025 | |
| Ambu INC. | $28.83 | 2024 | |
| Taiho Oncology, INC. | $28.44 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.48 | 2019 | |
| Eisai INC. | $15.76 | 2023 | |
| Myriad Genetic Laboratories, INC. | $13.86 | 2025 | Prolaris |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krisha Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.